Advertisement
Screener

AbbVie Inc. (ABBV) Graph

ABBV Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $16.99B; Cost of revenue $4.29B; Selling, general and administrative $3.63B; Income tax $662.00M.
  • 2026-03-31: Revenue $15.00B; Cost of revenue $4.22B; Selling, general and administrative $3.58B; Income tax $342.00M.
  • 2025-12-31: Revenue $16.62B; Cost of revenue $4.55B*; Selling, general and administrative $3.90B*; Income tax $853.00M*.
  • 2025-09-30: Revenue $15.78B; Cost of revenue $5.30B; Selling, general and administrative $3.57B; Income tax $526.00M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ABBV revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Other Products$1.11BRevenue$16.99BCost of revenue$4.29BOperating income$6.43BOther income, net-$1.48BSelling, general& administrative$3.63BPre-tax income$4.28BIncome tax$662.00M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2026-06-30$16.99B$4.29B$3.63B$662.00M$3.61B
2026-03-31$15.00B$4.22B$3.58B$342.00M$695.00M
2025-12-31$16.62B$4.55B*$3.90B*$853.00M*$1.82B
2025-09-30$15.78B$5.30B$3.57B$526.00M$186.00M
2025-06-30$15.42B$4.35B$3.25B$613.00M$938.00M
2025-03-31$13.34B$4.00B$3.29B$372.00M$1.29B
2024-12-31$15.10B(m)(m)(m)-$22.00M
2024-09-30$14.46B$4.21B$4.21B$520.00M$1.56B
2024-06-30$14.46B$4.20B$3.38B$773.00M$1.37B
2024-03-31$12.31B$4.09B$3.31B$383.00M$1.37B
2023-12-31$14.30B(m)(m)(m)$822.00M
2023-09-30$13.93B$6.49B$3.37B$172.00M$1.78B
2023-06-30$13.87B$4.24B$3.27B$583.00M$2.02B
2023-03-31$12.22B$3.99B$3.04B$234.00M$239.00M
2022-12-31$15.12B(m)(m)(m)$2.47B
2022-09-30$14.81B$5.02B$3.30B$448.00M$3.95B
2022-06-30$14.58B$4.17B$5.41B$255.00M$924.00M
2022-03-31$13.54B$4.05B$3.13B$436.00M$4.49B
2021-12-31$14.89B(m)(m)(m)$4.04B
2021-09-30$14.34B$4.39B$3.08B$508.00M$3.18B
2021-06-30$13.96B$4.52B$3.16B$394.00M$766.00M
2021-03-31$13.01B$4.21B$2.84B$312.00M$3.55B
2020-12-31$13.86B(m)(m)(m)$36.00M
2020-09-30$12.90B$5.05B$2.85B$187.00M$2.31B
2020-06-30$10.43B$3.71B$3.53B$46.00M-$738.00M
2020-03-31$8.62B$1.94B$1.70B$88.00M$3.01B
2019-12-31$8.70B(m)(m)(m)$2.80B
2019-09-30$8.48B$1.92B$1.66B$117.00M$1.88B
2019-06-30$8.26B$1.82B$1.65B$66.00M$741.00M
2019-03-31$7.83B$1.69B$1.68B$88.00M$2.46B
2018-12-31$8.30B(m)(m)(m)-$1.83B
2018-09-30$8.24B$1.83B$1.92B$14.00M$2.75B
2018-06-30$8.28B$1.93B$1.76B$29.00M$1.98B
2018-03-31$7.93B$1.93B$1.79B$14.00M$2.78B
2017-12-31$7.74B(m)(m)(m)$52.00M
2017-09-30$7.00B$1.62B$1.46B$464.00M$1.63B
2017-06-30$6.94B(m)$1.51B$438.00M$1.92B
2017-03-31$6.54B(m)$1.37B$375.00M$1.71B
2016-12-31$6.80B(m)(m)(m)$1.39B
2016-09-30$6.43B(m)$1.38B$416.00M$1.60B
2016-06-30$6.45B(m)$1.47B$486.00M$1.61B
2016-03-31$5.96B(m)$1.35B$422.00M$1.35B
2015-12-31$6.40B(m)(m)(m)$1.52B
2015-09-30$5.94B(m)$1.47B$408.00M$1.24B
2015-06-30$5.47B(m)$1.70B$312.00M$1.37B
2015-03-31$5.04B(m)$1.47B$374.00M$1.02B
2014-12-31$5.45B(m)(m)(m)(m)
2014-09-30$5.02B(m)$1.59B$181.00M(m)
2014-06-30$4.93B(m)$1.45B$335.00M(m)
2014-03-31$4.56B(m)$1.34B$306.00M(m)
2013-12-31$5.11B(m)(m)(m)(m)
2013-09-30$4.66B(m)$1.26B$322.00M(m)
2013-06-30$4.69B(m)$1.41B$300.00M(m)
2013-03-31$4.33B(m)$1.24B$271.00M(m)
2012-12-31$5.21B(m)(m)(m)(m)
2012-09-30$4.51B(m)$1.08B$19.00M(m)
2012-06-30$4.49B(m)$1.25B$135.00M(m)
2012-03-31$4.17B(m)$1.25B$123.00M(m)

Revenue and expense 6 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2026-06-30$31.99B$8.51B$7.21B$1.00B$4.31B
2025-06-30$28.77B$8.35B$6.55B$985.00M$2.22B
2024-06-30$26.77B$8.30B$6.69B$1.16B$2.74B
2023-06-30$26.09B$8.23B$6.31B$817.00M$2.26B
2022-06-30$28.12B$8.22B$8.54B$691.00M$5.41B
2021-06-30$26.97B$8.74B$6.01B$706.00M$4.32B
2020-06-30$19.04B$5.65B$5.22B$134.00M$2.27B
2019-06-30$16.08B$3.51B$3.33B$154.00M$3.20B
2018-06-30$16.21B$3.86B$3.55B$43.00M$4.77B
2017-06-30$13.48B(m)$2.88B$813.00M$3.63B
2016-06-30$12.41B(m)$2.82B$908.00M$2.96B
2015-06-30$10.52B(m)$3.18B$686.00M(m)
2014-06-30$9.49B(m)$2.79B$641.00M(m)
2013-06-30$9.02B(m)$2.64B$571.00M(m)
2012-06-30$8.67B(m)$2.49B$258.00M(m)

Revenue and expense 9 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2025-09-30$44.54B$13.65B$10.12B$1.51B$2.41B
2024-09-30$41.23B$12.51B$10.90B$1.68B$4.30B
2023-09-30$40.02B$14.71B$9.68B$989.00M$4.04B
2022-09-30$42.93B$13.24B$11.84B$1.14B$9.36B
2021-09-30$41.31B$13.13B$9.09B$1.21B$7.50B
2020-09-30$31.95B$10.70B$8.07B$321.00M$4.58B
2019-09-30$24.56B$5.43B$4.99B$271.00M$5.08B
2018-09-30$24.45B$5.70B$5.47B$57.00M$7.51B
2017-09-30$20.48B$4.76B$4.34B$1.28B$5.26B
2016-09-30$18.84B(m)$4.20B$1.32B$4.56B
2015-09-30$16.46B(m)$4.65B$1.09B$3.63B
2014-09-30$14.51B(m)$4.38B$822.00M(m)
2013-09-30$13.68B(m)$3.90B$893.00M(m)
2012-09-30$13.17B(m)$3.58B$277.00M(m)

Revenue and expense 12 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2025-12-31$61.16B$18.20B$14.01B$2.36B$4.23B
2024-12-31$56.33B$16.90B$14.75B-$570.00M$4.28B
2023-12-31$54.32B$20.41B$12.87B$1.38B$4.86B
2022-12-31$58.05B$17.41B$15.26B$1.63B$11.84B
2021-12-31$56.20B$17.45B$12.35B$1.44B$11.54B
2020-12-31$45.80B$15.39B$11.30B-$1.22B$4.62B
2019-12-31$33.27B$7.44B$6.94B$544.00M$7.88B
2018-12-31$32.75B$7.72B$7.40B-$490.00M$5.69B
2017-12-31$28.22B$7.04B$6.29B$2.42B$5.31B
2016-12-31$25.64B$5.83B$5.88B$1.93B$5.95B
2015-12-31$22.86B(m)$6.39B$1.50B$5.14B
2014-12-31$19.96B(m)$7.72B$595.00M$1.77B
2013-12-31$18.79B(m)$5.35B$1.20B(m)
2012-12-31$18.38B(m)$4.99B$450.00M(m)
2011-12-31$17.44B(m)$5.89B$235.00M(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Merck & Co., Inc. (MRK)United States$365.215B99.96
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60